These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2720692)

  • 1. Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy.
    Los G; Mutsaers PH; van der Vijgh WJ; Baldew GS; de Graaf PW; McVie JG
    Cancer Res; 1989 Jun; 49(12):3380-4. PubMed ID: 2720692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity.
    Los G; Smals OA; van Vugt MJ; van der Vlist M; den Engelse L; McVie JG; Pinedo HM
    Cancer Res; 1992 Mar; 52(5):1252-8. PubMed ID: 1737387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.
    Casper ES; Kelsen DP; Alcock NW; Lewis JL
    Cancer Treat Rep; 1983 Mar; 67(3):235-8. PubMed ID: 6682012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distribution of cis-diamminedichloroplatinum in patients with metastatic brain tumors after intravenous or intracarotid administration].
    Nakagawa H; Fujita T; Izumoto S; Kubo S; Nakajima Y; Turuzono K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):103-9. PubMed ID: 1987891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C; Huang R; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.
    Esquis P; Consolo D; Magnin G; Pointaire P; Moretto P; Ynsa MD; Beltramo JL; Drogoul C; Simonet M; Benoit L; Rat P; Chauffert B
    Ann Surg; 2006 Jul; 244(1):106-12. PubMed ID: 16794395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
    Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Zuhowski EG; Pluim D; Joseph E; Hamburger DR; Working PK; Colbern G; Tonda ME; Potter DM; Eiseman JL
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):329-36. PubMed ID: 14673619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II).
    Stewart DJ; Benjamin RS; Zimmerman S; Caprioli RM; Wallace S; Chuang V; Calvo D; Samuels M; Bonura J; Loo TL
    Cancer Res; 1983 Feb; 43(2):917-20. PubMed ID: 6681533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-clinical study of the epinephrine-cisplatin association for the treatment of intraperitoneal carcinomatosis.
    Favoulet P; Magnin G; Guilland JC; Beltramo JL; Osmak L; Benoit L; Rat P; Douvier S; Duvillard C; Chauffert B
    Eur J Surg Oncol; 2001 Feb; 27(1):59-64. PubMed ID: 11237494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.
    Howell SB; Pfeifle CE; Wung WE; Olshen RA
    Cancer Res; 1983 Mar; 43(3):1426-31. PubMed ID: 6681730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
    Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L
    Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.
    Reed E; Litterst CL; Thill CC; Yuspa SH; Poirier MC
    Cancer Res; 1987 Feb; 47(3):718-22. PubMed ID: 3802077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
    Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
    Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
    BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of adjuvant hyaluronidase in tumors refractory to chemotherapy. Review of the literature and pharmacokinetics of cisplatin after regional administration in animals and humans].
    Civalleri D; Esposito M; De Cian F; Balletto N; Vannozzi MO; Mondini G; Carrabetta S; Bocchio MM
    G Chir; 1997 Apr; 18(4):175-81. PubMed ID: 9303630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model.
    Pestieau SR; Stuart OA; Sugarbaker PH
    Eur J Surg Oncol; 2000 Nov; 26(7):696-700. PubMed ID: 11078617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment.
    Los G; Mutsaers PH; Lenglet WJ; Baldew GS; McVie JG
    Cancer Chemother Pharmacol; 1990; 25(6):389-94. PubMed ID: 2311166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy.
    Los G; Verdegaal EM; Mutsaers PH; McVie JG
    Cancer Chemother Pharmacol; 1991; 28(3):159-65. PubMed ID: 1855272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.